Skip to content

Yew Bio-Pharm Group, Inc.: 10-Q filed 2021-11-15

What Yew Bio-Pharm Group, Inc. reported in its quarterly report filed 2021-11-15 (fiscal Q3 2021): 41 published measures, 106 facts as tagged in accession 0001493152-21-028337.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-15
Fiscal period
fiscal Q3 2021
Accession
0001493152-21-028337 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Yew Bio-Pharm Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3061,396,842USD
At 2020-12-3158,446,662USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-3014,598,742USD
At 2020-12-3112,964,094USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3046,815,666USD
At 2020-12-3145,482,568USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3028,453USD
At 2020-12-31563,792USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,550,448USD92
2021-01-01 to 2021-09-30822,913USD273
2020-07-01 to 2020-09-30995,974USD92
2020-01-01 to 2020-09-301,884,953USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-306,930,855USD273
2020-01-01 to 2020-09-3012,210,618USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-30198,767USD273
2020-01-01 to 2020-09-30152,531USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-30110,106USD92
2021-01-01 to 2021-09-3023,690,989USD273
2020-07-01 to 2020-09-3010,355,215USD92
2020-01-01 to 2020-09-3021,946,554USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-3079,714USD273
2020-01-01 to 2020-09-30-418,005USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-7,356,398USD273
2020-01-01 to 2020-09-30-11,087,186USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-3032,238,518USD
At 2020-12-3131,415,605USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-01-01 to 2021-09-301,859USD273
2020-07-01 to 2020-09-3027,152USD92
2020-01-01 to 2020-09-3027,152USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-30534,205USD
At 2020-12-31516,921USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,558,268USD92
2021-01-01 to 2021-09-30977,798USD273
2020-07-01 to 2020-09-301,494,178USD92
2020-01-01 to 2020-09-302,508,066USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3013,933,641USD
At 2020-12-319,989,384USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-3012,544,060USD
At 2020-12-3110,525,110USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30791,404USD
At 2020-12-31423,881USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-302,704,268USD
At 2020-12-31217,689USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-30718,200USD92
2021-01-01 to 2021-09-30-1,088,921USD273
2020-07-01 to 2020-09-3031,180USD92
2020-01-01 to 2020-09-30744,930USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-30123,043USD
At 2020-12-3114,608USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-840,068USD92
2021-01-01 to 2021-09-30-111,123USD273
2020-07-01 to 2020-09-301,525,358USD92
2020-01-01 to 2020-09-303,252,996USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-07-01 to 2021-09-30950,174USD92
2021-01-01 to 2021-09-3023,802,112USD273
2020-07-01 to 2020-09-308,829,857USD92
2020-01-01 to 2020-09-3018,693,558USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2021-07-01 to 2021-09-30211,640USD92
2021-01-01 to 2021-09-30693,698USD273
2020-07-01 to 2020-09-30203,561USD92
2020-01-01 to 2020-09-30720,505USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3051,700,000shares
At 2020-12-3151,700,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-309,644,731USD
At 2020-12-319,644,731USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-09-301,118,429USD
At 2020-12-31608,244USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2021-09-3046,798,100USD
At 2020-12-3145,482,568USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30292,605USD
At 2020-12-31333,402USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30311,227USD
At 2020-12-31357,885USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-30131,245USD
At 2020-12-3190,989USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,558,694USD92
2021-01-01 to 2021-09-30807,534USD273
2020-07-01 to 2020-09-301,023,126USD92
2020-01-01 to 2020-09-301,912,105USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,558,694USD92
2021-01-01 to 2021-09-30805,675USD273
2020-07-01 to 2020-09-30995,974USD92
2020-01-01 to 2020-09-301,884,953USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,519,315USD92
2021-01-01 to 2021-09-301,316,188USD273
2020-07-01 to 2020-09-302,667,077USD92
2020-01-01 to 2020-09-302,842,301USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-01-01 to 2021-09-3051,461USD273
2020-01-01 to 2020-09-3040,363USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-3044,600USD92
2021-01-01 to 2021-09-30226,204USD273
2020-07-01 to 2020-09-3027,235USD92
2020-01-01 to 2020-09-3040,652USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-426USD92
2021-01-01 to 2021-09-30-170,264USD273
2020-07-01 to 2020-09-30-471,052USD92
2020-01-01 to 2020-09-30-595,961USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-30254,504USD273
2020-01-01 to 2020-09-30359,483USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2020-01-01 to 2020-09-3027,152USD274

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2021-01-01 to 2021-09-3067,394USD273
2020-01-01 to 2020-09-3034,725USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-302,473,767USD273
2020-01-01 to 2020-09-30-5,602,258USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-141,974USD273
2020-01-01 to 2020-09-30-94,847USD274

Inspect the source

Entity
Yew Bio-Pharm Group, Inc. / CIK 0001548240
Captured
SEC response SHA-256
42d239bf62595328b4b0f26c5a40397396731e01ab6dfcaf5b29c1b41870e6be

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001548240.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))